These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


219 related items for PubMed ID: 17088004

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension.
    Mathai SC, Bueso M, Hummers LK, Boyce D, Lechtzin N, Le Pavec J, Campo A, Champion HC, Housten T, Forfia PR, Zaiman AL, Wigley FM, Girgis RE, Hassoun PM.
    Eur Respir J; 2010 Jan; 35(1):95-104. PubMed ID: 19643943
    [Abstract] [Full Text] [Related]

  • 6. N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study.
    Thakkar V, Stevens WM, Prior D, Moore OA, Byron J, Liew D, Patterson K, Hissaria P, Roddy J, Zochling J, Sahhar J, Nash P, Tymms K, Celermajer D, Gabbay E, Youssef P, Proudman SM, Nikpour M.
    Arthritis Res Ther; 2012 Jun 12; 14(3):R143. PubMed ID: 22691291
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis.
    Allanore Y, Borderie D, Avouac J, Zerkak D, Meune C, Hachulla E, Mouthon L, Guillevin L, Meyer O, Ekindjian OG, Weber S, Kahan A.
    Arthritis Rheum; 2008 Jan 12; 58(1):284-91. PubMed ID: 18163505
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Non-invasive diagnostic and functional evaluation of cardiac involvement in patients with systemic sclerosis.
    Ciurzyński M, Bienias P, Lichodziejewska B, Kurnicka K, Szewczyk A, Glińska-Wielochowska M, Kurzyna M, Błaszczyk M, Liszewska-Pfejfer D, Pruszczyk P.
    Clin Rheumatol; 2008 Aug 12; 27(8):991-7. PubMed ID: 18256871
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.
    Fijalkowska A, Kurzyna M, Torbicki A, Szewczyk G, Florczyk M, Pruszczyk P, Szturmowicz M.
    Chest; 2006 May 12; 129(5):1313-21. PubMed ID: 16685024
    [Abstract] [Full Text] [Related]

  • 14. N-terminal probrain natriuretic peptide as a biochemical marker in the evaluation of bosentan treatment in systemic-sclerosis-related pulmonary arterial hypertension.
    Dimitroulas T, Giannakoulas G, Karvounis H, Koliakos G, Sfetsios T, Dimitroula H, Settas L.
    Clin Rheumatol; 2008 May 12; 27(5):655-8. PubMed ID: 18204995
    [Abstract] [Full Text] [Related]

  • 15. Cardiac biomarkers in systemic sclerosis: contribution of high-sensitivity cardiac troponin in addition to N-terminal pro-brain natriuretic peptide.
    Avouac J, Meune C, Chenevier-Gobeaux C, Borderie D, Lefevre G, Kahan A, Allanore Y.
    Arthritis Care Res (Hoboken); 2015 Jul 12; 67(7):1022-30. PubMed ID: 25604469
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Plasma N-terminal pro-brain natriuretic peptide levels are positively correlated with pulmonary arterial pressure in atrial septal defect patients.
    Li ZF, Zhou DX, Wang QB, Pan WZ, Zhang L, Ge JB.
    Regul Pept; 2013 May 10; 183():13-6. PubMed ID: 23499807
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.
    Williams MH, Handler CE, Akram R, Smith CJ, Das C, Smee J, Nair D, Denton CP, Black CM, Coghlan JG.
    Eur Heart J; 2006 Jun 10; 27(12):1485-94. PubMed ID: 16682379
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.